Conference Detail Page

Secondary Prevention of Ischemic Stroke: What’s Antiplatelet Therapy Got to Do With It?

CME : 0.5 +3
Start Date :  Dec 24 - 2020 End Date :  Dec 24 - 2021

Organized by :   Medscape, LLC

Specialities :   Stroke and Cerebrovascular

Conference Summary

Secondary Prevention of Ischemic Stroke: What’s Antiplatelet Therapy Got to Do With It? is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 12/24/2020
Valid for credit through: 12/24/2021

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

For Nurses
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

For Pharmacists
Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-20-427-H01-P).

Goal Statement:
The goal of this activity is to guide clinicians on new data for the secondary prevention of ischemic stroke, what the new data mean for practice, and how to safely and effectively apply these data to patient care.

Learning Objectives:
Upon completion of this activity, participants will:

• Have increased knowledge regarding the
○ Gaps related to secondary prevention of ischemic strokes
○ Clinical trial data related to secondary prevention of recurrent stroke in patients with acute ischemic stroke or high-risk transient ischemic stroke (TIA)
• Have greater competence related to
○ Application of clinical trial data related to secondary prevention of ischemic stroke in real-world patients

Credit Info

  • CME : 0.5
  • MOC : 0.5
  • Contact Hours : 0.5
  • CEUs : 0.5
Target Audience

This activity is intended for neurologists, cardiologists, primary care physicians, nurses, and pharmacists.

Peers Info
Number of Health Care Professionals Registered: 0 Number
Contact Us

Toll free Number

1(800) 826-2059


Chat Assistant

Live Chat